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Abstract
Background:  Patients increasingly seek more active involvement in health care decisions, but
little is known about how to communicate complex risk information to patients. The objective of
this study was to elicit patient preferences for the presentation and framing of complex risk
information.
Method:  To accomplish this, eight focus group discussions and 15 one-on-one interviews were
conducted, where women were presented with risk data in a variety of different graphical formats,
metrics, and time horizons. Risk data were based on a hypothetical woman's risk for coronary heart
disease, hip fracture, and breast cancer, with and without hormone replacement therapy.
Participants' preferences were assessed using likert scales, ranking, and abstractions of focus group
discussions.
Results:  Forty peri- and postmenopausal women were recruited through hospital fliers (n = 25)
and a community health fair (n = 15). Mean age was 51 years, 50% were non-Caucasian, and all had
completed high school. Bar graphs were preferred by 83% of participants over line graphs,
thermometer graphs, 100 representative faces, and survival curves. Lifetime risk estimates were
preferred over 10 or 20-year horizons, and absolute risks were preferred over relative risks and
number needed to treat.
Conclusion: Athough there are many different formats for presenting and framing risk
information, simple bar charts depicting absolute lifetime risk were rated and ranked highest overall
for patient preferences for format.
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Background
With the rising trend towards consumerism in health,
patients are increasingly encouraged to become involved
in making decisions about their health. Marketing cam-
paigns for prescription drugs are now being directed to-
wards patients, with advertisements appearing in the
popular press suggesting that patients discuss medica-
tions and treatment options with their doctors. A recent
study examining the effect of drug advertisements on
consumer behavior found that 19% of study participants
asked for a prescription, and 35% asked a physician for
information about a drug after seeing a drug advertise-
ment [1]. In order for patients to be effective participants
in the decision making process, they need information
on the effects of treatment on their health risks that they
can use to make health care decisions. The challenge to
clinicians is how to present risk information to patients
that they can use in a format that they prefer.
Several studies have examined how presentation, [2–4]
wording, [5] and framing [6,7] affect physicians' inter-
pretations of numeric data as well as their willingness to
initiate treatment [8]. However, few studies have exam-
ined the effect on patients of framing risk data with dif-
ferent metrics, such as relative or absolute risk and the
number needed to treat (NNT). Relative risk describes
the ratio of the risk of disease in one group compared to
that in another and does not take into consideration a
person's baseline risk. Absolute risk describes the differ-
ence between the risks of disease in two populations and
varies according to baseline risk. A derivative of absolute
risk is the NNT with a specific therapy to prevent one ad-
verse outcome (the inverse of the difference in absolute
risk). Framing the benefits of treatment in relative rather
than absolute terms may emphasize the short-term ben-
efits of a treatment [6,9]. Conversely, framing the risks of
treatment in relative rather than absolute terms may em-
phasize its risks [10]. Comparing relative and absolute
risk reduction and NNT as methods to inform patients
about preventive therapies, Hux et al illustrated that the
metric used to present data can affect a patient's percep-
tion of a therapy's effectiveness [11].
In addition to consideration of which metric is used to
describe risks, the time horizon over which risks or ben-
efits occur may affect risk interpretation. Typically, risks
framed in relative terms are not explicit about the time
frame involved and may be erroneously interpreted as
accruing immediately. On the other hand, risks framed
in absolute terms or as the NNT tend to report a specific
time frame and hence may be interpreted as being de-
layed in onset. In addition to issues related to compre-
hension, patients may prefer to have risks presented over
specific time periods.
While most framing studies focused on a treatment's ef-
fect on a single outcome over a single time horizon, pa-
tients often need to decide on treatments that affect
multiple outcomes, both beneficial and harmful. For ex-
ample, the decision of whether or not to use hormone re-
placement therapy (HRT) after menopause involves
weighing the benefits of treatment (immediate symptom
relief, [12] decreased future risk of hip fracture [13] and
possible decreased risk of coronary heart disease [14,15])
against its risks (increased future risk of breast cancer
[15]). Framing effects appear to be smaller when both the
beneficial and harmful effects of a treatment are includ-
ed, [16] but little information is available to guide clini-
cians about how to explain complex risk information to
their patients.
Most studies exploring risk communication and deci-
sion-making have focused on the use of different metrics.
However, data can be described using a variety of differ-
ent graphical formats as well. Survival curves are com-
monly used in the scientific literature and can also be
used to help patients understand risk information when
deciding between two treatments [2]. Figures using 100
faces or ovals to represent populations with and without
a condition, displayed in a random [17] or consolidated
[18] fashion, have gained increasing popularity in the lay
press, as have simple bar charts.
The choice of graphical formats may affect patient per-
formance on cognitive tests, [19–23] accuracy of com-
prehension, and speed of processing probabilistic
information. Vertical bars, horizontal bars, numbers,
and 100 consolidated ovals performed better than either
pie charts or 100 random ovals when testing simplified
cognitive tasks (e.g., identifying the larger of two quanti-
ties) [24]. The type of visual graphic used to present in-
formation can also introduce bias in risk perception,
with risk perceived to be less when using a bar graph ver-
sus a stick figure [25].
Numerous criteria have been used to evaluate graphical
formats, including clarity, helpfulness,[26,27] accuracy
and efficiency, [24] though these criteria may not neces-
sarily be those of greatest importance to patients them-
selves. Although it is unclear which criteria should be
used to evaluate formats to use with patients, patient
preferences may be an important consideration. Formats
preferred by patients may reflect higher perceived rele-
vance, familiarity, usefulness, usability, and meaningful-
ness, and hence may be more successful in engaging
their attention. The aim of this study is to determine pa-
tient preferences for the presentation of complex bene-
fit/risk information describing the impact of treatment
on multiple clinical outcomes over multiple time hori-
zons, including preferences for graphic format,time hori-BMC Medical Informatics and Decision Making (2001) 1:2 http://www.biomedcentral.com/1472-6947/1/2
zons, multiple outcomes comparisons, and metrics. The
specific example tested was deciding on HRT among a
population of peri-and postmenopausal women.
Methods
Peri- and postmenopausal women were recruited for
participation through hospital fliers and advertisements.
Focus groups were convened to discuss decision-making
issues about HRT as well as patient preference for risk
presentation. Recruitment ceased when convergence
was reached on the broader topics addressed. Of the 37
women who responded to fliers and ads, 25 participated
in 8 focus group sessions held at New England Medical
Center from March through May 1999. No information
was obtained on women who did not attend a focus
group. Each 2-hour session was conducted by 2 facilita-
tors (NFC, LKH) and was audio taped. All tapes were
transcribed and reviewed for subjective evaluation. Be-
cause most of the focus group participants were Cauca-
sian, 15 non-Caucasian women were recruited to
participate in one-on-one interviews through a commu-
nity health fair.
All participants were asked to evaluate different ways of
communicating risk estimates for coronary heart dis-
ease, hip fracture, and breast cancer, both with and with-
out HRT. All risk estimates were derived from a Markov
model [28] that used individual risk factors to predict fu-
ture disease risk. Risk estimates were based on a hypo-
thetical 50-year old woman's risk factor profile and were
displayed over 10-year, 20-year and lifetime horizons.
All graphical presentations depicted identical numerical
risk levels, differing only in the metrics and formats
used. To avoid "group think" resulting from focus group
discussions, participants were asked to privately record
their preferences on a worksheet before the group dis-
cussion convened. These worksheets were collected after
the discussions and data were extracted and analyzed.
Specific reasons for participants' preferences were elicit-
ed using open-ended questions.
Graphic format
We identified the following graphic formats as being the
most commonly used in the scientific and popular press,
and therefore the most recognizable to patients: bar
graphs, line graphs, thermometer graphs, 100 represent-
ative faces displayed in a consolidated fashion, and sur-
vival curves (Figures 1, 2). The survival curve was
atypical in that its y-axis presented a patient's chance of
not developing a disease instead of the more standard
"chance of survival". This modification was made to keep
the data presented consistent with data presented in the
other graphical formats since survival was not presented
in the other graphs (the chance of not developing a dis-
ease is the closest equivalent to survival, which is the
chance of not dying). Pie charts were not included be-
cause this format did not readily lend itself to describing
risks over time. Participants were sequentially presented
with all graphic formats and each was briefly explained.
Participants were asked to rate how much they liked each
graph on a likert scale of 1 to 5, with 1 corresponding to
"not at all" and 5 corresponding to "extremely", and then
to rank order the graphs according to preference.
Time horizons
Participants were also asked to rank order their prefer-
ences for risk estimates over 10-year, 20-year, or lifetime
horizons, presented using bar graphs predicting a wom-
an's risk for developing heart disease, hip fracture and
breast cancer.
Multiple Outcomes
Participants' preferences for risk displays about multiple
clinical outcomes were elicited by asking participants to
choose between 2 sets of 3 graphs. In Set A, each of three
diseases was displayed separately over 3 time horizons
(Figure 3). In Set B, the same three diseases were dis-
played together over one time horizon; this was repeated
for the other two time horizons (Figure 4). Note that the
exact same data were presented in each set, differing
only in format.
Metrics
Preferences for absolute vs. relative risk estimates were
obtained by asking participants to choose between risk
estimates for heart disease framed in either absolute or
relative terms, both graphically and textually. Finally,
participants evaluated the concept of NNT presented
with two written explanations. The first explanation (re-
ferred to as "1 in x") was worded "If 8 women just like you
took lifelong HRT, it would prevent one of the 8 from
having heart disease. If 9 women took lifelong HRT, it
would prevent one of the 9 from having a hip fracture. If
17 women took lifelong HRT, it would cause one of the 17
to develop breast cancer. There is no way of knowing in
advance who these women might be." The alternative ex-
planation (referred to as "x out of 100") was worded "If
100 women just like you were to take lifelong HRT, treat-
ment would prevent 12 of them from developing heart
disease and 11 of them from developing a hip fracture.
However, treatment would cause 6 of them to develop
breast cancer. There is no way of knowing in advance
who these women might be."
We assessed differences in patients' preferences between
the two graphs with the highest mean rating using a Wil-
coxon signed-rank test. Descriptive statistics were per-
formed on subgroups stratified according to race
(Caucasian vs. non-Caucasian), annual household in-
come (<$50,000 vs.≥ $50,000), and education (<2 yearsBMC Medical Informatics and Decision Making (2001) 1:2 http://www.biomedcentral.com/1472-6947/1/2
college vs. ≥  2 years college). Statistical comparisons
within subgroups were not performed due to the small
sample size.
Results
Study participants included a diverse group of 40 peri-
and post-menopausal women (Table 1). Half of our sam-
ple identified themselves as non-Caucasian. All partici-
pants had at least some high school education; most
(60%) had an annual household income of less than
$50,000.
The mean preference rating for the bar graph exceeded
those of the four other graphs in this set (Table 2). Most
respondents (83%) ranked the bar graph as being their
first or second most preferred graph, with more than half
of all respondents (60%) selecting the bar graph as their
first choice (Figure 5). The bar graph was consistently
rated highest when the sample population was stratified
according to race, income and educational status. Sub-
group analyses are shown in Table 2, recognizing that
these analyses are limited considering the small sample
size.
Most respondents preferred receiving risk estimates over
multiple time horizons vs. at one time point. When asked
to prioritize, a majority preferred receiving lifetime risk
estimates instead of 10 or 20-year time horizons (Table
3a). There was no clear preference for the type of presen-
tation comparing risks for multiple disease outcomes
over different time horizons (Table 3b). Respondents
preferred risk estimates framed in absolute rather than
relative terms for both graphical and textual displays
(Table 3c); this finding was consistent across racial, in-
come, and educational sub-groups. Participants consist-
ently stated that they wanted graphical and textual
explanations of absolute risks provided together. In de-
scribing NNT, respondents preferred the written expla-
nation which rescaled data from "1-in x" to "x out of 100"
(Table 3d).
Table 1: Demographic Characteristics of Sample Population
Sample size 40 women
Mean age, yrs (range) 51 (38–67)
Age group, yrs
< 45 6
45–55 24
> 55 10
Race
Non-Caucasian 20
Caucasian/Non-Hispanic White 20
Annual Household Income
Less than $25,000 11
$25,000–$49,999 13
$50,000–$74,999 5
$75,000–$99,999 5
$100,000 or more 6
Highest Level of Education Completed
Grade 9–12 6
Technical/Vocational 3
2 years of college 12
4 years of college 9
Post-graduate degree 10
Table 2: Mean Preference Ratings of Graphical Displays of Risk Information (SD)
Display† Overall Non-Caucasian Caucasian Lower income Higher income Lower education Higher education
(n = 40) (n = 20) (n = 20) (n = 24) (n = 16) (n = 9) (n = 31)
1. Bar graph 4.0‡(1.0) 3.5(1.1) 4.4 (0.7) 4.0(1.0) 3.9(1.0) 3.4(1.2) 4.1 (0.9)
2. Line graph 3.1 (0.9) 3.2(0.9) 3.0 (0.9) 3.0(1.0) 3.2(0.8) 2.9(1.1) 3.1 (0.9)
3. Thermometer 2.6(1.1) 2.7(1.0) 2.5(1.1) 2.6(1.1) 2.6(1.1) 2.4 (0.9) 2.7(1.1)
graph
4. 100 faces 2.4(1.5) 2.6(1.5) 2.2(1.5) 2.8(1.5) 1.8(1.3) 3.3(1.1) 2.1 (1.5)
5. Survival curves § 2.5(1.1) 2.3(1.1) 2.9(1.0) 2.6(1.2) 2.4 (0.9) 2.6(1.1) 2.5(1.1)
†Lower income reflects annual household income below $49,999; higher income reflects annual household income above $50,000. Lower education 
reflects completion of grades 9–12 or Technical/Vocational school. Higher education reflects 2 or 4 years of college or a post-graduate degree. ‡Wil-
coxon signed rank test for difference between bar and line graph ratings (p < 0.001). § Presented to 35 participants (20 non-Caucasian, 15 Caucasians; 
22 lower income, 13 higher income; 7 lower education, 28 higher education). Percentages reflect appropriate adjustments.BMC Medical Informatics and Decision Making (2001) 1:2 http://www.biomedcentral.com/1472-6947/1/2
Discussion
Whereas no single format for communicating risk esti-
mates was favored by all respondents, the majority of our
sample population preferred a bar graph over a line
graph, a thermometer graph, 100 faces, and a survival
curve. Focus group participants remarked that the bar
graph was "real basic" and "simplistic, I could deal with
that". Respondents also commented that this graph type
"shows the information clearer" than other graph choic-
es. We could not exclude the possibility that participants
preferred formats that were more familiar to them, but
no one explicitly reported that as being a consideration.
There was a smaller difference in mean preference rating
among non-Caucasian than among Caucasian respond-
ents. It is possible that this was due to the fact that these
discussions were conducted 1-on-1 as opposed to focus
group discussions. However, this is not likely as the 1-on-
1 discussions were time-constrained and highly focused.
The largest difference in graph preferences amongst the
sub-groups was the tendency of women who were non-
Caucasian, of lower income, or of lower educational sta-
tus to give the 100 faces figure a higher ranking than did
women who were Caucasian, had higher incomes, or
higher educational levels. However, this finding was
based on limited sub-group analyses. Whereas some par-
ticipants saw the 100 faces as being "more exact...there's
actual happy faces you can count", others remarked that
it was "too much, too busy" and "simple".
The majority of our participants indicated that they
would like to have their risk estimates presented over all
three time horizons. Arguments for having all three time
horizons included "obviously I want a healthy lifetime,
but whatever I do to fight these diseases, if I fight them
within the next ten years, that's going to stand me in
good stead for the rest of my life". However, when asked
to prioritize which single time horizon they preferred,
more than half preferred a lifetime estimate, with one re-
spondent commenting "I chose lifetime. I like to see it
all". This finding is consistent with those of Mazur et al.
who found that patients were more influenced by the
end-points of survival curves rather than the area or
shape of the survival curve. [2] This may denote a prefer-
ence for risk data to be presented as a lifetime estimate
instead of as points in time along an axis. Although phy-
sicians tend to report risks using intermediate data (such
as 5-year survival estimates) when recommending treat-
ments, [4] patients may be more interested in long-term
benefits and risks.
There was no clear consensus about whether graphs
should display one disease outcome over many time ho-
rizons or many disease outcomes for one time horizon,
even though slightly more respondents favored the lat-
ter. Respondents who wanted to see risk information as
three disease outcomes over one time horizon per graph
argued that they liked everything "all on one sheet", and
that "I might get breast cancer, but I wouldn't get this or
I wouldn't get that...sometimes it comes to a trade-off."
Arguments for presenting one disease outcome at a time
over many time horizons included "I would want to look
at my results...specifically just my osteoporosis risk...and
this is my heart disease and this is my cancer." Small
sample size limited the ability to explore whether a wom-
an's concern for a single (vs. multiple) disease predicted
her presentation preferences.
Also consistent with recent research, respondents pre-
ferred data framed in absolute rather than relative terms.
Whereas physicians may find relative risk estimates to be
valuable in deciding whether to recommend a treatment,
[29] framing data as absolute risk may be more informa-
tive and help patients who are making decisions about
Table 3: Preferences for Risk Information Presentations
a. Time Horizon 1st Choice 2nd Choice
(n = 40) (n = 33)
10-year 23% 12%
20-year 20% 58%
Lifetime 55% 27%
No response 3% 3%
b. Multiple diseases, multiple time Preference
horizons (n = 40)
Set A: 1 disease over 3 time horizons 53%
Set B: 3 diseases over 1 time horizon 43%
No response 5%
c. Relative vs. absolute risk Graph Text  Pre-
ference
Preference (n = 20)
(n = 25)
Relative risk 28% 30%
Absolute risk 72% 65%
No response 0% 5%
d. NNT Preference
(n = 40)
Standard explanation (1 in x) 28%
Alternative explanation (x out of 100) 45%
Neither 25%
No response 3%
*Percentages may not total 100% due to rounding.BMC Medical Informatics and Decision Making (2001) 1:2 http://www.biomedcentral.com/1472-6947/1/2
Figure 1
Graphical Displays of Risk Estimates: Bar Graph and Line GraphBMC Medical Informatics and Decision Making (2001) 1:2 http://www.biomedcentral.com/1472-6947/1/2
Figure 2
Graphical Displays of Risk Estimates: Thermometer Graph, 100 Faces, and Survival CurvesBMC Medical Informatics and Decision Making (2001) 1:2 http://www.biomedcentral.com/1472-6947/1/2
Figure 3
Risk Displays on Multiple Disease Outcomes Over Different Time Horizons, Set A: Each graph shows the risk for one disease
over multiple time horizons with and without HRT (1. Coronary Heart Disease, 2. Hip Fracture, 3. Breast Cancer).BMC Medical Informatics and Decision Making (2001) 1:2 http://www.biomedcentral.com/1472-6947/1/2
Figure 4
Risk Displays on Multiple Disease Outcomes Over Different Time Horizons, Set B: Each graph shows the risk for three dis-
eases over one time horizon with and without HRT (4. Ten-year estimates, 5. Twenty-year estimates, 6. Lifetime estimates).BMC Medical Informatics and Decision Making (2001) 1:2 http://www.biomedcentral.com/1472-6947/1/2
treatment options [29]. Focus group participants re-
marked that the graph presenting relative risk was "too
alarming because the risks appeared bigger". Also, one
respondent commented that she would "just want to
know that the example is 100%," referring to the absolute
risk graph presented on a 100% scale as opposed to the
40% scale used in the relative risk graph.
Few respondents preferred their risk estimates to be pre-
sented as NNT. Although this concept may be useful to
physicians because it accounts for differences in baseline
risks, [30] it did not find favor among our study partici-
pants who remarked that the concept was "confusing"
and often asked focus group leaders for clarification.
This finding is consistent with results by Cook et al who
found that explaining risk estimates in terms of NNT
during patient rounds can be time consuming and sub-
ject to patient misinterpretation [31].
Limitations
The present study included a small, self-selected popula-
tion of women who were more likely to be interested in
health-related activities. Our sample size was small be-
cause focus groups and 1-on-1 interviews were originally
conducted to discuss HRT and decision-making issues.
When convergence was reached on these broader topics,
we ceased recruitment and analyzed data from these re-
spondents. While these results may not be generalizable
to all women, our sample included a diverse group of
women with respect to race, income, and educational
background. Recognizing that focus group discussions
might lead to "group think", we control for this by asking
participants to privately write down their personal pref-
erences before they were discussed.
A formal analysis of patient comprehension for each
presentation format was beyond the scope of the present
study; however data on this topic has been previously re-
ported [24]. While responses from focus group partici-
pants reflected how well they felt they could understand
the information in various formats, no formal testing of
comprehension was performed. Analyzing comprehen-
sion of each format at this stage was not feasible consid-
ering the additional time burden it would have imposed
on our study participants (focus group sessions lasted a
full 2 hours). Presentation formats that are not under-
standable may be misinterpreted; formats that are unap-
pealing may be ignored. Therefore, future studies might
test both comprehension and patient preferences simul-
taneously to develop future risk communication tools.
The graphical presentations utilized were hypothetical in
that they did not present each individual's personal risk
estimates, but those of a theoretical woman. It is unlikely
that patients' preferences for risk estimate presentations
would have been different had they been shown their
own risk estimates. Not all possible graph types were
presented to study participants, although we attempted
to include the most common graph types from the scien-
tific and popular press. Although we did not systemati-
cally study the reasons for participants' stated
preferences, participants were asked open-ended ques-
tions to understand these preferences. Finally, since sci-
entific literature traditionally presents 5-year survival
data, it might be difficult to compare our data, based on
10-year, 20-year and lifetime horizons, to that in the cur-
rent literature.
Conclusions
Patients preferred health risks to be framed in absolute
terms, using bar graphs, and calculated over their ex-
pected lifetime. There was no clear preference for pre-
senting a treatment's effect on multiple outcomes. The
NNT is not an easily understood concept for patients, but
if used to discuss multiple outcomes, it should be re-
scaled to "x out of 100". The results of these analyses
should help physicians present risk/benefit information
to patients in a clear and useful manner.
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